Sonoma Biotherapeutics Funding & Investors
South San Francisco, CA
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.
sonomabio.comTotal Amount Raised: $365,000,000
Sonoma Biotherapeutics Funding Rounds
Corporate Round
$30,000,000
Corporate Round Investors
Regeneron PharmaceuticalsSeries B
$265,000,000
Series B Investors
Ally Bridge GroupFidelity InvestmentsNS InvestmentJDRF T1D FundLilly Asia VenturesArrowMark Partners8 | partnersVertex Ventures HCCasdin CapitalGVAvidity Partners ManagementLifeforce CapitalArch Venture PartnersJanus HendersonAlexandria Venture InvestmentsMirae AssetDeep Track CapitalOsage IndustriesFrazier ManagementOctagon Capital AdvisorsSeries A
$30,000,000
Series A Investors
Arch Venture Partners8 | partnersLilly Asia VenturesLyell ImmunopharmaJDRF T1D FundAlexandria Venture InvestmentsLifeforce CapitalOctagon Capital AdvisorsSeries A
$40,000,000
Series A Investors
Lyell Immunopharma8 | partnersMilky Way VenturesArch Venture Partners
Funding info provided by Diffbot.